| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Supplements |
1 From the Environmental Epidemiology Program, Department of Environmental Health, Harvard School of Public Health, Channing Laboratory, Department of Medicine, Harvard Medical School, Boston.
DF Horrobin hypothesized that the low prevalence of lung disease among Eskimos is the result of their diet, which is high in n-3 fatty acids. The n-3 and n-6 fatty acids shunt eicosanoid production away from the arachidonic acid pathway, and hence decrease the production of bronchoconstrictive leukotrienes. Animal studies showed that eicosapentaenoic acid or 
-linolenic acid supplementation of animals exposed to endotoxins results in decreased effects on thromboxane B2 and pulmonary vascular resistance. Small human trials confirmed that supplementation with eicosapentaenoic acid results in increased eicosapentaenoic acid in phospholipids and decreased generation of leukotrienes by neutrophils. Hence, a protective effect of such fatty acids in lung disease is biologically plausible. The results of human intervention studies looking at respiratory outcomes have been mixed, but they do suggest a possible difference between long-term and short-term effects. Epidemiologic studies showed possible protective effects against asthma in children, but weak to no evidence of such effects in adults. Results for bronchitis are more positive, although intervention trials are lacking. Recently, a cross-sectional analysis of data from the first National Health and Nutrition Examination Survey reported an 
80-mL difference in forced expiratory volume at 1 s between adults with high compared with low fish consumption. This response was not limited to asthmatic subjects. Others found that both fish consumption and n-3 fatty acid consumption (as estimated from food-frequency questionnaires) were protective against physician-diagnosed emphysema and chronic bronchitis and low spirometry values. Only smokers were included in this analysis. These results suggest that dietary fatty acids may play a role in lung disease; further work is needed to elucidate that role.
Key Words: Lung disease • diet • fish oil • n–3 fatty acids • polyunsaturated fatty acids • PUFAs • eicosapentaenoic acid • asthma • bronchitis
This article has been cited by other articles:
|
|
 |
|
  F. Gottrand Long-Chain Polyunsaturated Fatty Acids Influence the Immune System of Infants J. Nutr., September 1, 2008; 138(9): 1807S - 1812S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T M McKeever, S A Lewis, P A Cassano, M Ocke, P Burney, J Britton, and H A Smit The relation between dietary intake of individual fatty acids, FEV1 and respiratory disease in Dutch adults Thorax, March 1, 2008; 63(3): 208 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Burns, D. W. Dockery, L. M. Neas, J. Schwartz, B. A. Coull, M. Raizenne, and F. E. Speizer Low Dietary Nutrient Intakes and Respiratory Health in Adolescents Chest, July 1, 2007; 132(1): 238 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pierre, M.-O. Husson, R. L. Berre, J.-L. Desseyn, C. Galabert, L. Beghin, C. Beermann, A. Dagenais, Y. Berthiaume, B. Cardinaud, et al. Omega-3 polyunsaturated fatty acids improve host response in chronic Pseudomonas aeruginosa lung infection in mice Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1422 - L1431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lee, K. M. Gura, S. Kim, D. A. Arsenault, B. R. Bistrian, and M. Puder Current Clinical Applications of {Omega}-6 and {Omega}-3 Fatty Acids Nutr Clin Pract, August 1, 2006; 21(4): 323 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Jho, S. M. Cole, E. M. Lee, and N. J. Espat Role of Omega-3 Fatty Acid Supplementation in Inflammation and Malignancy Integr Cancer Ther, June 1, 2004; 3(2): 98 - 111. [Abstract] [PDF]
|
|
|
|
 |
|
 R. K Woods, E H. Walters, J. M Raven, R. Wolfe, P. D Ireland, F. C. Thien, and M. J Abramson Food and nutrient intakes and asthma risk in young adults Am. J. Clinical Nutrition, September 1, 2003; 78(3): 414 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Ardies Inflammation as Cause for Scar Cancers of the Lung Integr Cancer Ther, September 1, 2003; 2(3): 238 - 246. [Abstract] [PDF]
|
|
|
|
 |
|
 J.M. Anto, P. Vermeire, J. Vestbo, and J. Sunyer Epidemiology of chronic obstructive pulmonary disease Eur. Respir. J., May 1, 2001; 17(5): 982 - 994. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
